Arctic Bioscience to Present at H.C. Wainwright Bioconnect Conference
Arctic Bioscience, a biotech company developing and commercializing nutraceutical and pharmaceutical products based on the unique properties of bioactive marine compounds, will present at the US investment bank H.C. Wainwright’s Bioconnect Virtual Conference – discussing the company's phase IIb clinical trial, 2021 accomplishments, long term-strategy and 2022 priorities.H.C. Wainwright Bioconnect Conference Details: Date: January 10[th] from 13.00 CESTLink: Arctic Bioscience company presentation Full event details: